Re: Use of CD34+ internal controls

From: g.gwhite (g.gwhite@xtra.co.nz)
Date: Thu Dec 06 2001 - 02:38:34 EST


Hi Emanuel,

R&D systems have a product called Statusflow Pro which is a stabilised whole
blood control
enriched with 2% CD34+ cells.
The product insert contains instrustions for use with the ISHAGE gating.
I tried a vial 6 months ago and it seemed to work well with our ISHAGE
template.
The CD34+ cells are possibly a little brighter than mobilised PBSC's.
Another advantage of this control is it has values for approx 20 different
CD antigens.

Regards,

Glennis White
Haematology Laboratory
Wellington Hospital
New Zealand
glennis.white@ccdhb.org.nz


----- Original Message -----
From: Emanuel Raniolo <emanuel.raniolo@imvs.sa.gov.au>
To: cyto-inbox
Sent: Tuesday, November 27, 2001 1:33 PM
Subject: Use of CD34+ internal controls


>
> Hi all
>
> Our standard method for CD34 enumeration is a dual platform ISHAGE gated
> (wash) method.
> In order to establish and validate a single platform (no wash) ISHAGE
method
> in the laboratory, it would be nice to be able to run an internal control.
>
> I have used Beckman-Coulter's commercial Stem-Trol control cells for this
> purpose, but have been unable to recover the stated assayed concentration.
> In fact I my determinations are consistently higher than the allowable +/-
> 15% range.
>
> Apart from some difficulties in gating placement, as these cells display
> increased forward and side light scatter characteristics to normal human
> haematopoetic precursors, I cannot see why my results are too high (around
> 40% above the stated concentration). I practice reverse pipetting, and mix
> the fluorospheres adequately prior to dispensing.  Single vs dual platform
> comparisons for peripheral blood demonstrate a small positive bias in
favour
> of the single platform method, whereas results are identical for apheresis
> product. In addition, the absolute CD45+ count is in general agreement
with
> the analyser WBC count.
>
> I would like to ask:
> What is the group experience with the use of internal controls for CD34
> enumeration, and in particular with Stem-Trol cells?
> Is the stated Stem-Trol assayed concentration and range reflective of
common
> experience?
> Are internal CD34+ controls regularly utilised in routine practice?
> What alternative sources are available?
>
> Thanks
>
> Emanuel Raniolo
> IMVS Laboratories
> The Queen Elizabeth Hospital
> Department of Haematology
> Cell Analysis and Cryopreservation Laboratory
> Adelaide, South Australia.
>
>



This archive was generated by hypermail 2b29 : Sun Jan 05 2003 - 19:01:42 EST